HomeInsightsAnalyst Perspectives

Analyst Perspectives

Signed point-of-view pieces — where our specialists say what the data means, and what they'd do about it. Every view carries a name.

240 perspectives · 28 analysts
“The category’s center of gravity has moved from the gym to the pantry.”

Why the everyday functional-snacking buyer — not the elite athlete — will define the next decade of protein, and what brands must reformulate to win them.

Priya Nair
Lead Analyst, Food & Nutrition
7 min
“Don’t buy the hydrogen headline — buy the sub-market.”

A 54% blended CAGR conceals three markets growing at very different speeds, with very different winners. Where the durable economics actually are.

Daniel Okafor
Principal Analyst, Energy & Power
8 min
“AI video has crossed from demo to deployment — selectively.”

Paying demand is real but concentrated. The three use-cases generating revenue today, and why the rest are still burning capital.

Mei Lin Chen
Senior Analyst, ICT & AI
6 min
“Clean label stopped being a premium and became a permit.”

Reformulation is now the cost of shelf access, not a differentiator. What that does to margins across the snacking category.

Priya Nair
Lead Analyst, Food & Nutrition
5 min
“Packaging, not lithography, is the chip story of the decade.”

As node scaling slows, advanced packaging is where performance and capacity constraints now concentrate. The supply-side map.

Arjun Mehta
Principal Analyst, Semiconductors
8 min
“Storage is quietly out-executing every flashier energy bet.”

Grid-scale storage lacks the hype of hydrogen, but the unit economics are landing faster. Where capacity is being built and by whom.

Daniel Okafor
Principal Analyst, Energy & Power
7 min
“Automation’s growth is real — its deployment is uneven.”

Separating pilots from production. Which business functions are actually paying for workflow automation today, and which are stalling.

Mei Lin Chen
Senior Analyst, ICT & AI
7 min
“Collagen demand is supply-constrained, not demand-constrained.”

Wound care and orthobiologics are pulling medical-grade collagen. The bottleneck — and the margin — sits upstream.

Sofia Alvarez
Senior Analyst, Healthcare
6 min